Successful treatment of periostomal pyoderma gangrenosum using topical tacrolimus [15]

British Journal of Dermatology

Volumn 150, Issue 2, 2004, Pages 387-388

  Vidal, D ^a   Alomar, A ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; ORABASE; TACROLIMUS; UNCLASSIFIED DRUG;

AGED; ANAMNESIS; BACTERIOLOGY; CAPSULE FILLING; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CREAM; CULTURE MEDIUM; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG FORMULATION; ENTERITIS; FOLLOW UP; HUMAN; HUMAN TISSUE; LETTER; MAINTENANCE THERAPY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; NEOPLASM; OINTMENT; PERIOSTEUM; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; SIDE EFFECT; SKIN BIOPSY; SKIN MANIFESTATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; AGED; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PYODERMA GANGRENOSUM; TACROLIMUS; TREATMENT OUTCOME;

EID: 1542506933     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2003.05804.x     Document Type: Letter

References (5)

1. Lyon CC, Smith AJ, Beck MH et al. Parastomal pyoderma gangrenosum: clinical features and management. J Am Acad Dermatol 2000; 42: 992-1002.
2. Jolles S, Niclasse S, Benson E. Combination oral and topical tacrolimus in therapy-resistant pyoderma gangrenosum. Br J Dermatol 1999; 140: 564-5.
3. Reich K, Vente C, Neumann C. Topical tacrolimus for pyoderma gangrenosum. Br J Dermatol 1998; 139: 755-7.
4. Schuppe HC, Homey B, Assmann T et al. Topical tacrolimus for pyoderma gangrenosum. Lancet 1998; 351: 832.
5. Lyon CC, Stapleton M, Smith AJ et al. Topical tacrolimus in the management of periostomal pyoderma gangrenosum. J Dermatol Treat 2001; 12: 13-17.